Delivery Order W9114F26DA005-HT940626FE026

The Defense Health Agency awarded a delivery order to Roche Diagnostics S.P.A. on January 2, 2026, for clinical chemistry cost per reportable result services. The contract is structured as a firm fixed-price delivery order with a ceiling value of $3,439.76 and an ultimate completion date of February 28, 2026. The work will be performed in Italy, and no set-aside designation was used in this procurement. Roche Diagnostics S.P.A. is identified as a child entity under UEI CRBLKCZC9XC6. This...

The Defense Health Agency awarded a delivery order valued at $482,006 to Roche Diagnostics Corporation for chemistry and immunoassay laboratory testing services on a cost-per-reportable-result basis. This non-set-aside contract, effective May 1, 2022, through April 1, 2023, will be performed at Roche's facility in Castleton, Indiana. The award utilizes firm fixed-price pricing under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration schedule, enabling the federal...

Roche Diagnostics Corporation was awarded a delivery order valued at $1.18 million by the Defense Health Agency on July 1, 2024, for the provision of clinical chemistry analyzer equipment and cost-per-reportable-result reagents and consumables for clinical laboratory chemistry and immunoassay testing. The order supports two Naval Hospital locations—Camp Pendleton and Bremerton—with performance completion scheduled for May 14, 2026. This delivery order is a child contract under the Critical...

The Defense Health Agency (DHA) awarded a delivery order valued at $1.66M to Roche Diagnostics Corporation for cost-per-reportable-results (CPRR) diagnostic services. This firm fixed-price delivery order, which commenced on October 1, 2025, and extends through September 30, 2026, represents a child contract under a larger DHA indefinite delivery vehicle. The award was made without set-aside designation, reflecting open competition. Roche Diagnostics Corporation, a foreign-owned in vitro...

The Defense Health Agency awarded a $2.21M delivery order to Roche Diagnostics Corporation for chemistry and immunoassay testing services, effective October 1, 2025, with completion targeted for September 30, 2026. This firm fixed-price contract represents a child order under a larger vehicle and carries no set-aside designation, allowing Roche to compete openly in the federal marketplace. The work will be performed at Fort Sam Houston in San Antonio, Texas, a major military medical facility....

The Defense Health Agency awarded a $397,692.13 delivery order to Roche Diagnostics Corporation for continued chemistry and immunoassay testing services on a cost-per-reportable-result (CPRR) basis. This child delivery order, designated as W81K0024F0153, is scheduled for completion by April 4, 2026, and will be performed at Fort Sam Houston in San Antonio, Texas. The contract employs firm fixed-price pricing without set-aside designation, reflecting open competition. Roche Diagnostics...

The Defense Health Agency awarded a $147,897.25 firm fixed-price delivery order to Roche Diagnostics Corporation for consumables delivery, with a completion date of January 30, 2026. The delivery order, which represents a child contract with no set-aside designation, will be performed in Castleton, Indiana. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis, specializes in in vitro diagnostic solutions, laboratory instruments, and reagents for clinical...

The Defense Health Agency awarded a $182,375.48 firm fixed-price contract call to Roche Diagnostics Corporation for chemistry analyzer and reagents on a cost-per-reportable-result pricing model. The contract, which commenced October 1, 2025, and extends through January 31, 2026, represents a call against an existing Blanket Purchase Agreement valued at $606,000 through March 2027. This award is unaccompanied by any set-aside designation, indicating open competition. The place of performance is...

The Defense Health Agency has awarded a delivery order valued at $2.19M to Roche Diagnostics Corporation for core laboratory chemistry testing services through September 30, 2025. This firm fixed-price delivery order, which was awarded on October 1, 2024, will be performed at Fort Sam Houston in San Antonio, Texas, supporting the military healthcare system's diagnostic testing capabilities. The award carries no set-aside designation, indicating it was competed openly in the federal...

The Defense Health Agency awarded a $24,547.20 firm fixed-price call order to Roche Diagnostics Corporation for blood testing reagents required to perform medical laboratory testing. The award, issued on December 19, 2025, is scheduled for completion by September 30, 2026, and represents a child contract under a larger blanket purchase agreement vehicle. The work will be performed at Roche's facility in Castleton, Indiana. No set-aside designation was applied to this procurement, indicating open...